Dramatic reduction in infective endocarditis-related mortality with a management-based approach

Archives of Internal Medicine

Volumn 169, Issue 14, 2009, Pages 1290-1298

  Botelho Nevers, Elisabeth ^a   Thuny, Franck ^a,b   Casalta, Jean Paul ^a   Richet, Hervé ^a   Gouriet, Frédérique ^a   Collart, Frédéric ^b   Riberi, Alberto ^b   Habib, Gilbert ^a,b   Raoult, Didier ^a,c  

^a CNRS   (France)

^b TIMONE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; GENTAMICIN; METICILLIN; OXACILLIN; PENICILLIN DERIVATIVE; VANCOMYCIN;

ACTINOBACILLUS; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CAPNOCYTOPHAGA; CARDIOBACTERIUM HOMINIS; CAUSE OF DEATH; CLINICAL PRACTICE; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMORBIDITY; CONFIDENCE INTERVAL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMBOLISM; ENTEROCOCCUS; FEMALE; FOLLOW UP; HAEMOPHILUS; HEART FAILURE; HEART VALVE SURGERY; HUMAN; IATROGENIC DISEASE; KIDNEY FAILURE; KINGELLA; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RECOMMENDED DRUG DOSE; STREPTOCOCCUS; SURVIVAL RATE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; CLINICAL PROTOCOLS; ENDOCARDITIS; EVIDENCE-BASED MEDICINE; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED;

EID: 67749103705     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.192     Document Type: Article

References (46)

1. Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363(9403):139-149.
2. Prendergast BD. The changing face of infective endocarditis. Heart. 2006;92(7):879-885.
3. Horstkotte D, Follath F, Gutschik E, et al; Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J. 2004;25(3):267-276.
4. Wilson WR, Karchmer AW, Dajani AS, et al; American Heart Association. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA. 1995;274(21):1706-1713.
5. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):e394-e434.
6. Hoen B, Alla F, Selton-Suty C, et al; Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288(1):75-81.
7. Fefer P, Raveh D, Rudensky B, Schlesinger Y, Yinnon AM. Changing epidemiology of infective endocarditis: a retrospective survey of 108 cases, 1990-1999. Eur J Clin Microbiol Infect Dis. 2002;21(6):432-437.
8. Benn M, Hagelskjaer LH, Tvede M. Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. J Intern Med. 1997;242(1):15-22.
9. Muhlestein JB. Infective endocarditis: how well are we managing our patients? J Am Coll Cardiol. 1999;33(3):794-795.
10. Delahaye F, Rial MO, de Gevigney G, Ecochard R, Delaye J. A critical appraisal of the quality of the management of infective endocarditis. J Am Coll Cardiol. 1999;33(3):788-793.
11. González De Molina M, Fernández-Guerrero JC, Azpitarte J. Infectious endocarditis: degree of discordance between clinical guidelines recommendations and clinical practice [in Spanish]. Rev Esp Cardiol. 2002;55(8):793-800.
12. Raoult D, Casalta JP, Richet H, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005;43(10):5238-5242.
13. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732.
14. Barrau K, Boulamery A, Imbert G, et al. Causative organisms of infective endocarditis according to host status. Clin Microbiol Infect. 2004;10(4):302-308.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
16. Durack DT, Lukes AS, Bright DK; Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96(3):200-209.
17. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-638.
18. Greub G, Lepidi H, Rovery C, et al. Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med. 2005;118(3):230-238.
19. Lepidi H, Durack DT, Raoult D. Diagnostic methods current best practices and guidelines for histologic evaluation in infective endocarditis. Infect Dis Clin North Am. 2002;16(2):339-361, ix.
20. Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005;91(5):571-575.
21. Bonow RO, Carabello B, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 1998;98(18):1949-1984.
22. Therneau T, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer-Verlag; 2000.
23. Gagliardi JP, Nettles RE, McCarty DE, Sanders LL, Corey GR, Sexton DJ. Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database. Clin Infect Dis. 1998;26(5):1165-1168.
24. Peled N, Pitlik S, Livni G, Ashkenazi S, Bishara J. Impact of age on clinical features and outcome of infective endocarditis. Eur J Clin Microbiol Infect Dis. 2006;25(7):473-475.
25. Lalani T, Kanafani ZA, Chu VH, et al; The International Collaboration on Endocarditis Merged Database Study Group. Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur J Clin Microbiol Infect Dis. 2006;25(6):365-368.
26. Zamorano J, de Isla LP, Malangatana G, et al. Infective endocarditis: mid-term prognosis in patients with good in-hospital outcome. J Heart Valve Dis. 2005;14(3):303-309.
27. Bishara J, Leibovici L, Gartman-Israel D, et al. Long-term outcome of infective endocarditis: the impact of early surgical intervention. Clin Infect Dis. 2001;33(10):1636-1643.
28. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore). 1995;74(6):324-339.
29. Dyson C, Barnes RA, Harrison GA. Infective endocarditis: an epidemiological review of 128 episodes. J Infect. 1999;38(2):87-93.
30. Bouza E, Menasalvas A, Munoz P, Vasallo FJ, del Mar Moreno M, Garcia Fernandez MA. Infective endocarditis-a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore). 2001;80(5):298-307.
31. Mouly S, Ruimy R, Launay O, et al. The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect. 2002;45(4):246-256.
32. Netzer RO, Altwegg SC, Zollinger E, Tauber M, Carrel T, Seiler C. Infective endocarditis: determinants of long term outcome. Heart. 2002;88(1):61-66.
33. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88(1):53-60.
34. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003;289(15):1933-1940.
35. Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109(14):1745-1749.
36. Jassal DS, Neilan TG, Pradhan AD, et al. Surgical management of infective endocarditis: early predictors of short-term morbidity and mortality. Ann Thorac Surg. 2006;82(2):524-529.
37. Heiro M, Helenius H, Makila S, et al. Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004. Heart. 2006;92(10):1457-1462.
38. Cicalini S, Puro V, Angeletti C, Chinello P, Macri G, Petrosillo N. Profile of infective endocarditis in a referral hospital over the last 24 years. J Infect. 2006;52(2):140-146.
39. Tornos P. Infective endocarditis: a serious and rare condition that needs to be handled in experienced hospitals [in Spanish]. Rev Esp Cardiol. 2005;58(10):1145-1147.
40. Anguita Sánchez M, Torres Calvo F, Castillo Dominguez JC, et al. Short- and long-term prognosis of infective endocarditis in non-injection drug users: improved results over 15 years (1987-2001) [in Spanish]. Rev Esp Cardiol. 2005;58(10):1188-1196.
41. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115(13):1721-1728.
42. Aksoy O, Meyer LT, Cabell CH, Kourany WM, Pappas PA, Sexton DJ. Gender differences in infective endocarditis: pre- and co-morbid conditions lead to different management and outcomes in female patients. Scand J Infect Dis. 2007;39(2):101-107.
43. Bisbe J, Miro JM, Latorre X, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis. 1992;15(6):910-923.
44. Gilbert DN, Eliopoulos GM, Moellering RC, Sande MA. Endocarditis: Sanford Guide to Antimicrobial Therapy. Sperryville, VA: Antimicrobial Therapy Inc; 2008:26-28.
45. Baily MA. Harming through protection? N Engl J Med. 2008;358(8):768-769.
46. Murdoch DR, Corey GR, Hoen B, et al; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463-473.